Jim Charnetski
GM, Integrated Deals
Expertise:
Jim is responsible for designing and implementing integrated commercial solutions with an emphasis on leveraging data and predictive analytics to drive empirically-based, go-to-market commercial decisions for pharmaceutical, biotech and life science organizations. Jim brings nearly 30 years of biopharmaceutical experience to this role. Prior to joining EVERSANA, Jim held various senior-level roles at Quintiles/IQVIA, Health Products Research (HPR) and Scott-Levin.
Jim is an industry subject matter expert in the areas of Launch Planning, Commercial Effectiveness and the development of Voice of the Customer platforms centered on delivering superior value and engagement. He has frequently spoken at pharma industry conferences and been cited by industry publications on trends in healthcare promotion, the Rx market and the use of patient-level data assets to optimize launch success. Jim has supported over 100 launches during his career
Articles by Jim Charnetski
Use of Machine Learning to Accurately Size Market Potential and Optimize Sales and Marketing Resources
Machine Learning as a strategic lever in healthcare. Recent advances in Machine Learning (ML) now make it possible for pharmaceutical companies to more accurately identify patient populations, including misdiagnosed patients with rare diseases and other diseases that have a high prevalence of symptomatic related diagnoses, along with their healthcare providers. With this knowledge, it also […]